Eurofins goes fully operational with new Central Laboratory in Singapore
08-May-2007
Eurofins announced that their recently established Central Laboratory in Singapore is now fully operational and, operating under the Eurofins | Medinet brand, extends its network of central laboratories in Europe and the US into Asia to provide safety testing for our customers in the pharmaceutical clinical trial and drug development sector.
Eurofins commenced the construction of the facility in November 2006 and obtained its operational license from the Singapore Ministry of Health in early 2007. Located in the Synergy Building of the International Business Park, the laboratory contains state-of-the art equipment and was developed rapidly in response to strong customer interest.
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Early Detection by Tango - Fast, uncomplicated, and specific: diagnosis of prostate cancer from blood samples
New organ-on-chip pilot seeks to reduce animal testing in consumer health industry - Cooperation between Bayer, the start-ups esqLABS and Dynamic42, and Placenta Lab of Jena University Hospital
A vast viral world in wastewater - How metagenomic sequencing helps to understand the spread of viruses
Atomic-scale view of bacterial proteins offers path to new tuberculosis drugs
Ebolaviruses need very few mutations to cause disease in new host species
Sequenom to Begin Clinical Assessment of Noninvasive Screening Technology for Down Syndrome
Frozen noble gas in the accelerator
Symyx Appoints New President of High Productivity Research
Nanomedicines on their way through the body - Which pathways do nanomedicines take after they have been swallowed?
